Patent application number | Description | Published |
20090202979 | Production of antibody formats and immunological applications of said formats - The invention concerns an in-vitro method for introducing a targeted genome modification into an oocyte or an egg and a method for performing a random insertion in the genome of a host cell. | 08-13-2009 |
20090214541 | Combination Therapy Using Anti-EGFR and Anti-HER2 Antibodies - The invention relates to the combined use of anti-EGFR antibodies and anti-Her2 antibodies for the treatment of cancer, especially suitable for cancer expressing high levels of the EGFR type and low levels of HER2. The invention refers in particular monoclonal antibody “trastuzumab” (HERCEPTIN®) directed against the HER2 receptors the efficacy of which can be significantly increased in vivo when combined with monoclonal antibody “matuzumab” (hmAB 425, EMD 72000) directed against EGF receptors. The combination treatment is suitable for patients suffering from cancer having said receptor profile, preferably pancreatic cancer. | 08-27-2009 |
20100135996 | MONOCLONAL ANTIBODIES AND FRAGMENT THEREOF DIRECTED AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II) - The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers. | 06-03-2010 |
20110110929 | HUMAN ANTI-IDIOTYPIC ANTIBODY FRAGMENTS THAT MIMIC HER-2/NEU - This invention relates to human anti-idiotype antibody fragments, especially scFv, characterized by the ability to mimic Her-2/neu tumor associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients positive for Her-2/neu. | 05-12-2011 |
20120308477 | BRIEF RADIOIMMUNOTHERAPY - The present invention relates to a method of treating a subject having a cancer in a body cavity characterized in that it comprises the steps of:
| 12-06-2012 |
20130164300 | MONOCLONAL ANTIBODIES AND FRAGMENT THEREOF DIRECTED AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II) - The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers. | 06-27-2013 |
20140112931 | ANTI-HUMAN HER3 ANTIBODIES AND USES THEREOF - The present invention provides for isolated anti-human-HER3 antibodies or fragments thereof. More particularly the present invention provides an isolated monoclonal antibody that specifically binds to the extracellular domain of HER-3 and competes for binding to the extracellular domain of human HER-3 with the antibody produced obtainable from hybridoma deposited as CNCM-I-4486. The antibodies described in the present invention are useful for the treatment of cancer. | 04-24-2014 |
20140141019 | ANTIBODIES AGAINST HER3 - The invention relates to antibodies against HER3 and their use in the treatment of cancer. | 05-22-2014 |
Patent application number | Description | Published |
20100042432 | THERAPY DISCHARGE RECONCILIATION - Systems, methods, and computer-readable media for displaying therapy groupings and individual therapies for a patient on a display. At least one therapy grouping area comprising one or more therapy groupings is provided for a patient being discharged from a current care venue. The therapy grouping comprises a therapy prescribed for or taken by the patient prior to visiting the current care venue associated with a therapy the patient was prescribed while visiting the current care venue. At least one previous therapy area is provided that includes an individual therapy prescribed for the patient prior to visiting a current care venue that has not been associated with a therapy the patient was prescribed while visiting the current care venue and at least one current therapy area comprising an individual therapy prescribed for the patient while visiting the current care venue that has not been associated with a therapy prescribed for or taken by the patient prior to visiting the current care venue. At least one interactive user input area is provided allowing a user to enter a discharge input for at least one therapy grouping. | 02-18-2010 |
20100042433 | CROSS CONTINUUM ASSOCIATED THERAPY RECONCILIATION - Systems, methods, and computer-readable media for associating one or more prior therapies with one or more current therapies for a patient are provided. One or more therapies a patient was taking or prescribed prior to visiting a current care venue are accessed. One or more therapies the patient is taking or has been prescribed at the current care venue for the current care venue visit are accessed. Input is received that one of the one or more prior therapies for the patient corresponds with one of the one or more current therapies for the patient. In response to receiving the input, the prior therapy is associated with the current therapy. The association of the corresponding prior therapy and the corresponding current care venue therapy is stored for the patient. | 02-18-2010 |
20100169109 | Managing Patient Care Plans - Systems, methods, and computer-readable media for managing patient care plans are provided. In embodiments, a patient care plan, including at least one order, is input into a patient profile. A user may proactively check for alerts related to the patient care plan or receive alert notification when signing the orders included in the patient care plan. Upon presentation of an alert, the user may re-enter the patient profile to correct input information, cancel the order associated with the alert, override the alert, and the like. In the case the alert is overridden, information related to the reason for overriding the alert is collected and preserved in an alert history for presentation to subsequent users. | 07-01-2010 |
20100169771 | User Interface for Managing Patient Care Plans - Systems, methods, and computer-readable media for managing patient care plans are provided. In embodiments, a graphical user interface provides for the presentation and management of patient care plans. The user interface includes a plan summary area that is configured to display information relating to a patient care plan. The user interface also includes a plan detail area configured to display an activated patient care plan that is indicated by an activated icon. Additional informational icons are displayed in both the plan summary area and the plan detail area. The activated patient care plan includes orders that are displayed in an order summary area. The number of orders of the patient care plan to be signed is indicated in the plan detail area. The user interface may also include a checks alerts input to proactively check alerts before signing the orders. | 07-01-2010 |
20100177337 | SELECTIVE ROUTING OF MEDICAL PRINTING REQUESTS - A computer system and method for selectively routing a printing request to the appropriate printer or printing component is provided. Patient-related and treatment-related information are received. The patient-related and/or treatment-related information are utilized to determine required printing features for the printing request, such as, for example, tamper-proof paper. The print request is routed to a printer having the required printing feature or features. | 07-15-2010 |